RECURRENT ACUTE BIPHENOTYPIC LEUKEMIA
Clinical trials for RECURRENT ACUTE BIPHENOTYPIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ACUTE BIPHENOTYPIC LEUKEMIA trials appear
Sign up with your email to follow new studies for RECURRENT ACUTE BIPHENOTYPIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise for tough blood cancers
Disease control Recruiting nowThis study tests a combination of four drugs (cladribine, idarubicin, cytarabine, and quizartinib) in people with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) that is either newly diagnosed or has returned/not responded to treatment. The goal is to see…
Matched conditions: RECURRENT ACUTE BIPHENOTYPIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
Engineered immune cells take aim at returning leukemia
Disease control Recruiting nowThis early-phase trial tests a new treatment for children and adults with acute leukemia that has come back or not responded after a donor stem cell transplant. The treatment uses specially engineered immune cells (T cells) from the original donor that are trained to recognize an…
Matched conditions: RECURRENT ACUTE BIPHENOTYPIC LEUKEMIA
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 18, 2026 12:03 UTC